Sep 1, 2026, 4:05 PM EDT · 4 weeks ago Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jul 28, 2026, 4:05 PM EDT · 2 months ago Pulmonx to Present at the Canaccord Genuity 46th Annual Growth Conference
Jul 15, 2026, 4:05 PM EDT · 2 months ago Pulmonx to Report Second Quarter 2026 Financial Results on July 29, 2026
Apr 28, 2026, 4:05 PM EDT · 5 months ago Pulmonx to Present at the Bank of America Securities 2026 Health Care Conference
Apr 15, 2026, 4:05 PM EDT · 5 months ago Pulmonx to Report First Quarter 2026 Financial Results on April 29, 2026
Mar 4, 2026, 4:06 PM EST · 7 months ago Pulmonx Reports Fourth Quarter and Full Year 2025 Financial Results
Mar 4, 2026, 4:05 PM EST · 7 months ago Pulmonx Announces Closing of up to $60 Million Credit Facility
Feb 20, 2026, 8:00 AM EST · 7 months ago Pulmonx to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026
Dec 3, 2025, 4:05 PM EST · 10 months ago Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2025-10-27T20:16:21.000Z · 11 months ago Pulmonx reports preliminary Q3 revenue $21.5M, consensus $20.78M
Oct 27, 2025, 4:05 PM EDT · 11 months ago Pulmonx Announces Management Transition and Preliminary Third Quarter 2025 Revenue; Reschedules Third Quarter 2025 Earnings Call to November 12, 2025
Oct 15, 2025, 4:05 PM EDT · 11 months ago Pulmonx to Report Third Quarter 2025 Financial Results on October 29, 2025
2025-07-30T20:15:53.000Z · 1 year ago Pulmonx cuts FY25 revenue view to $90M-$92M from $96M-$98M, consensus $96.95M
Jul 16, 2025, 4:05 PM EDT · 1 year ago Pulmonx to Report Second Quarter 2025 Financial Results on July 30, 2025
May 28, 2025, 4:05 PM EDT · 1 year ago Pulmonx to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
May 1, 2025, 4:05 PM EDT · 1 year ago Pulmonx to Present at the Bank of America Securities 2025 Health Care Conference
Feb 19, 2025, 4:05 PM EST · 1 year ago Pulmonx Reports Record Fourth Quarter and Full Year 2024 Financial Results
Feb 13, 2025, 4:05 PM EST · 1 year ago Pulmonx to Present at the Citi 2025 Unplugged Medtech and Life Sciences Access Day
Feb 5, 2025, 4:05 PM EST · 1 year ago Pulmonx to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025
Nov 20, 2024, 4:05 PM EST · 1 year ago Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference
Nov 19, 2024, 9:00 AM EST · 1 year ago Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers
Oct 16, 2024, 4:05 PM EDT · 1 year ago Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024
Sep 9, 2024, 4:05 PM EDT · 2 years ago Pulmonx Announces Presentation of Clinical Data from the AeriSeal® CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024
Aug 29, 2024, 4:05 PM EDT · 2 years ago Pulmonx to Participate in the Lake Street 8th Annual Best Ideas Growth Conference
Aug 22, 2024, 4:05 PM EDT · 2 years ago Pulmonx to Present at the 2024 Wells Fargo Healthcare Conference
Jul 29, 2024, 4:05 PM EDT · 2 years ago Pulmonx to Present at the Canaccord Genuity 44th Annual Growth Conference
Jul 10, 2024, 4:05 PM EDT · 2 years ago Pulmonx to Report Second Quarter 2024 Financial Results on July 31, 2024
Apr 10, 2024, 4:05 PM EDT · 2 years ago Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024
Apr 2, 2024, 4:05 PM EDT · 2 years ago Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer
Feb 26, 2024, 8:00 AM EST · 2 years ago Pulmonx Announces Treatment of the First Patient with the AeriSeal® System in CONVERT II Pivotal Trial
Feb 21, 2024, 4:06 PM EST · 2 years ago Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results
Feb 21, 2024, 4:05 PM EST · 2 years ago Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer
Feb 7, 2024, 4:05 PM EST · 2 years ago Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024
Nov 15, 2023, 4:05 PM EST · 2 years ago Pulmonx to Present at the Piper Sandler 35th Annual Healthcare Conference
Oct 16, 2023, 4:05 PM EDT · 2 years ago Pulmonx to Report Third Quarter 2023 Financial Results on October 30, 2023
Oct 10, 2023, 4:05 PM EDT · 2 years ago Pulmonx Announces CFO Transition and Record Preliminary Third Quarter 2023 Revenue
Jul 26, 2023, 4:05 PM EDT · 3 years ago Pulmonx to Present at the Canaccord Genuity 43rd Annual Growth Conference
Jul 17, 2023, 8:00 AM EDT · 3 years ago Pulmonx to Report Second Quarter 2023 Financial Results on August 2, 2023